<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2021, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 29 Apr 2021 11:38:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion</title>
   <link>http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</guid>
   <pubDate>Thu, 29 Apr 2021 11:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02472879</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03562356</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion</title>
   <link>http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</guid>
   <pubDate>Thu, 29 Apr 2021 11:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02472879</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03562356</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion</title>
   <link>http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</guid>
   <pubDate>Thu, 29 Apr 2021 11:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02472879</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03562356</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion</title>
   <link>http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</guid>
   <pubDate>Thu, 29 Apr 2021 11:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02472879</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03562356</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion</title>
   <link>http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</guid>
   <pubDate>Thu, 29 Apr 2021 11:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02472879</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03562356</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion</title>
   <link>http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</guid>
   <pubDate>Thu, 29 Apr 2021 11:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02472879</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03562356</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion</title>
   <link>http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</guid>
   <pubDate>Thu, 29 Apr 2021 11:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02472879</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03562356</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Istari Oncology Hires Marc Banjak as General Counsel and Secretary as the Company Prepares for a Critical Period of Development and Expansion</title>
   <link>http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Istari+Oncology+Hires+Marc+Banjak+as+General+Counsel+and+Secretary+as+the+Company+Prepares+for+a+Critical+Period+of+Development+and+Expansion/18332643.html</guid>
   <pubDate>Thu, 29 Apr 2021 11:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.02472879</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.03562356</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  15-12B     Dova Pharmaceuticals                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Dova+Pharmaceuticals+++++++++++++++++/16171203.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Dova+Pharmaceuticals+++++++++++++++++/16171203.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++15-12B+++++Dova+Pharmaceuticals+++++++++++++++++/16171203.html</guid>
   <pubDate>Fri, 22 Nov 2019 16:13:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  EFFECT     Dova Pharmaceuticals                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Dova+Pharmaceuticals+++++++++++++++++/16151294.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Dova+Pharmaceuticals+++++++++++++++++/16151294.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Dova+Pharmaceuticals+++++++++++++++++/16151294.html</guid>
   <pubDate>Tue, 19 Nov 2019 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  SC 13G/A   Dova Pharmaceuticals                   Filed by: PERCEPTIVE ADVISORS LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Dova+Pharmaceuticals+++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/16145995.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Dova+Pharmaceuticals+++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/16145995.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SC+13GA+++Dova+Pharmaceuticals+++++++++++++++++++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/16145995.html</guid>
   <pubDate>Mon, 18 Nov 2019 06:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  4          Dova Pharmaceuticals      For: Nov 12  Filed by: PERCEPTIVE ADVISORS LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/16145041.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/16145041.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+PERCEPTIVE+ADVISORS+LLC/16145041.html</guid>
   <pubDate>Fri, 15 Nov 2019 20:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  4          Dova Pharmaceuticals      For: Nov 12  Filed by: ZACCARDELLI DAVID</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+ZACCARDELLI+DAVID/16124454.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+ZACCARDELLI+DAVID/16124454.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+ZACCARDELLI+DAVID/16124454.html</guid>
   <pubDate>Tue, 12 Nov 2019 16:43:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  4          Dova Pharmaceuticals      For: Nov 12  Filed by: Wysenski Nancy</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Wysenski+Nancy/16124424.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Wysenski+Nancy/16124424.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Wysenski+Nancy/16124424.html</guid>
   <pubDate>Tue, 12 Nov 2019 16:42:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  4          Dova Pharmaceuticals      For: Nov 12  Filed by: Stalfort Sean</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Stalfort+Sean/16124397.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Stalfort+Sean/16124397.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Stalfort+Sean/16124397.html</guid>
   <pubDate>Tue, 12 Nov 2019 16:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  4          Dova Pharmaceuticals      For: Nov 12  Filed by: Novak Alfred J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Novak+Alfred+J/16124376.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Novak+Alfred+J/16124376.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Novak+Alfred+J/16124376.html</guid>
   <pubDate>Tue, 12 Nov 2019 16:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
  <item>
   <title>Form  4          Dova Pharmaceuticals      For: Nov 12  Filed by: Manning Paul B</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Manning+Paul+B/16124339.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Manning+Paul+B/16124339.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dova+Pharmaceuticals++++++For%3A+Nov+12++Filed+by%3A+Manning+Paul+B/16124339.html</guid>
   <pubDate>Tue, 12 Nov 2019 16:39:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DOVA</category>
   	  </item>
 </channel>
</rss>
